NEW YORK--(BUSINESS WIRE)--Sept. 17, 2003--Advanced Plant Pharmaceuticals, Inc. (APPI), a company that utilizes whole plants through a proprietary (patent pending) manufacturing process to develop all-natural Whole Plant Pharmaceuticals and Nutritionals, is pleased to announce that the company has received from a private investor a commitment to raise $500,000 for the company through a private placement. The investor has already forwarded to the company $100,000, the balance will be forwarded to the company by November 15, 2003.
With the following initiatives announced recently, the company deemed it prudent to strengthen its balance sheet in order to have the financial flexibility to advance its business plan on a broad front:
-- Building Lo-Chol(TM) sales nationally and internationally
through a media marketing campaign with its marketing partner.
-- Developing the Sinusol(TM) Market nationally and
internationally with marketing partners
-- Filing patent applications to protect the proprietary value of
the company's products
About Advanced Plant Pharmaceuticals, Inc.
Advanced Plant Pharmaceuticals, Inc. (APPI) focuses on the research and development of plant-based dietary and health supplements. The Company has a patent pending process that utilizes whole plants to manufacture all natural dietary and health supplements. APPI uses this process to manufacture products, which the company distributes worldwide through various marketing and distribution contracts. Current products include Sinusol (homeopathic allergy and nasal spray), Garlic, ABAVCA(TM) (immune system booster) and Lo-Chol(TM). Corporate website: www.appi.cc
FORWARD LOOKING STATEMENTS:
This release contains forward-looking statements within the meaning and pursuant to the Safe Harbor provisions of the Securities Litigation Reform Act of 1995 and involve risks and uncertainties that may individually or mutually impact the matters herein described, including but not limited to product development and acceptance, manufacturing, competition, regulatory and/or other factors, which are outside the control of the Company.